28 research outputs found

    In vitro synergism between estrogens and cytotoxic agents

    No full text
    SCOPUS: ar.jinfo:eu-repo/semantics/publishe

    Effect of an homo-aza-steroidal ester on estrogen receptor

    No full text
    SCOPUS: ar.jinfo:eu-repo/semantics/publishe

    Effect of CB 154 (2-Br-伪-Ergocryptine) on MXT mammary tumor growth

    No full text
    This work analyses the effect of the potent prolactin secretion inhibitor 2 Br-alpha-ergocryptine (CB 154) on both the acceptance and the growth of the mouse transplantable MXT ovarian-dependent mammary tumor. CB 154 was injected at doses of 25 mg/kg and 50 mg/kg subcutaneously for 10 weeks. This treatment did not decrease the tumor acceptance but delayed the appearance of palpable tumor nodules. Furthermore estimation of the change in tumor surface area (TS) expressed in sq mm revealed that the drug reduced tumor growth. This effect became significant after 8 weeks. Tumor death was also significantly delayed (7 surviving mice in controls versus 13 in the 25 mg/kg group, and 12 in the 50 mg/kg group). The present data suggest that the MXT mouse mammary tumor is sensitive to prolactin. This property associated with the known ovarian hormone sensitivity makes this tumor a valuable experimental model for assessing hormone dependence of mammary carcinomas.SCOPUS: NotDefined.jinfo:eu-repo/semantics/publishe

    Estrogen-induced protein in the human breast cancer cell line MCF7

    No full text
    SCOPUS: ar.jinfo:eu-repo/semantics/publishe

    Antagonism of cyclofenil and nafoxidine in the growth of the human breast cancer cell line MCF-7

    No full text
    SCOPUS: NotDefined.jinfo:eu-repo/semantics/publishe
    corecore